rs2934381
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024408.4(NOTCH2):c.1915+89C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.122 in 1,185,224 control chromosomes in the GnomAD database, including 11,221 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2970 hom., cov: 32)
Exomes 𝑓: 0.12 ( 8251 hom. )
Consequence
NOTCH2
NM_024408.4 intron
NM_024408.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.572
Publications
22 publications found
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
- acroosteolysis dominant typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- Alagille syndrome due to a NOTCH2 point mutationInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Alagille syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-119963485-G-A is Benign according to our data. Variant chr1-119963485-G-A is described in ClinVar as Benign. ClinVar VariationId is 1276223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NOTCH2 | ENST00000256646.7 | c.1915+89C>T | intron_variant | Intron 11 of 33 | 1 | NM_024408.4 | ENSP00000256646.2 | |||
| NOTCH2 | ENST00000479412.2 | n.2053+89C>T | intron_variant | Intron 10 of 13 | 1 | |||||
| NOTCH2 | ENST00000640021.1 | n.*1039+89C>T | intron_variant | Intron 8 of 11 | 5 | ENSP00000492223.1 |
Frequencies
GnomAD3 genomes AF: 0.168 AC: 25472AN: 152008Hom.: 2959 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25472
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.115 AC: 119173AN: 1033098Hom.: 8251 AF XY: 0.117 AC XY: 62458AN XY: 533098 show subpopulations
GnomAD4 exome
AF:
AC:
119173
AN:
1033098
Hom.:
AF XY:
AC XY:
62458
AN XY:
533098
show subpopulations
African (AFR)
AF:
AC:
8482
AN:
25272
American (AMR)
AF:
AC:
4039
AN:
44152
Ashkenazi Jewish (ASJ)
AF:
AC:
1670
AN:
23460
East Asian (EAS)
AF:
AC:
817
AN:
37786
South Asian (SAS)
AF:
AC:
14111
AN:
77230
European-Finnish (FIN)
AF:
AC:
6817
AN:
51064
Middle Eastern (MID)
AF:
AC:
420
AN:
4886
European-Non Finnish (NFE)
AF:
AC:
77267
AN:
723024
Other (OTH)
AF:
AC:
5550
AN:
46224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
5683
11366
17048
22731
28414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2378
4756
7134
9512
11890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.168 AC: 25504AN: 152126Hom.: 2970 Cov.: 32 AF XY: 0.167 AC XY: 12447AN XY: 74376 show subpopulations
GnomAD4 genome
AF:
AC:
25504
AN:
152126
Hom.:
Cov.:
32
AF XY:
AC XY:
12447
AN XY:
74376
show subpopulations
African (AFR)
AF:
AC:
13495
AN:
41470
American (AMR)
AF:
AC:
1625
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
289
AN:
3468
East Asian (EAS)
AF:
AC:
163
AN:
5176
South Asian (SAS)
AF:
AC:
910
AN:
4820
European-Finnish (FIN)
AF:
AC:
1421
AN:
10584
Middle Eastern (MID)
AF:
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7195
AN:
68004
Other (OTH)
AF:
AC:
329
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1020
2040
3059
4079
5099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
572
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.